Are there any other treatment options for my cancer?

Do you find yourself asking this question too?

In just three steps, we help you find innovative clinical trials, answer your questions, and arrange appointments – without obligation and free of charge.

Request free consultation

How do we help you get access  to innovative studies?

Our service is tailored to your personal situation:

1. Get in touch

Register with us and we will call you back: we listen to your wishes, explain which medical information we need, and answer your questions.

2. Personalised selection of studies

As soon as we receive your data, we will send you an overview of suitable clinical trials and further information within a few days.
This gives you time to review everything in peace and, if you wish, to discuss it with your doctor.

3. Contact with the study centre

If you are interested, we will organise contact with the study centres and arrange your first appointment.
Start study search
OnkoPlus Klinische Studienvermittlung

OnkoPlus is a free service provided by iduneo GmbH. We help you find innovative treatment options through clinical trials and clarify all details regarding participation – independently, without obligation, and free of charge.

Feel free to call us: +49 40 - 53 25 23 73

What patients tell us

“Thank you for your efforts, whether I end up joining the study or not. It is reassuring to know that your service exists!”

“Now I finally know that there are still other options for me!”


“I have already spoken with the study doctor and my first appointment is scheduled.”

Register here
LIFE SCIENCE NORD
Myelom Online
NVIDIA Inception Program
Microsoft for Startups - Founders Hub
Microsoft for Startups - Founders Hub

“According to current oncology guidelines, clinical trials should be considered as a treatment option. Unfortunately, this still happens too rarely.
We want to change that and open up more treatment options for patients.”

Dr. med. Steffen Achenbach, Co-Founder of OnkoPlus

Learn more

New approaches in research

Various new therapies are currently being researched in studies that open up new perspectives for the treatment of cancer or malignant haematological diseases.

Researchers are testing medicines that specifically target abnormal genetic changes in tumour cells. For example, drugs are being developed for patients with a TP53 gene mutation to help repair defective genes and make treatment more effective.

This treatment uses the body’s own immune cells (T cells). In the laboratory, these cells are modified so that they can specifically recognise and destroy cancer cells. They are then returned to the patient. This therapy is currently being investigated in clinical trials.

Cancer cells are often able to repair damage to their DNA themselves. These medicines block this repair mechanism and make cancer cells more vulnerable. They are particularly suitable for tumours with certain genetic alterations (changes in the genetic material of the cancer cell).

Certain viruses are modified so that they preferentially infect and destroy cancer cells, while healthy cells are left as unharmed as possible.

Frequently Asked Questions (FAQ)

We are happy to answer your questions in a personal conversation.
Below you will already find answers to some of the most common questions.
Your question is not listed here? Please feel free to contact us – we are here to help.

A clinical trial is a research study in which new medicines, treatments or medical procedures are tested in people to find out how safe and effective they are.
These studies are essential for developing new treatment options and driving medical progress.

We search for clinical trials for all oncological and haematological diseases.
Whether you have a solid tumour or a blood cancer, we support you in finding a suitable study.

Yes. The search for suitable clinical trials and our support in choosing between them are completely free of charge for you.

No. Participation in a clinical trial is free of charge for you. All necessary medical examinations and study drugs provided as part of the trial are covered.
In many studies, participants also receive compensation for expenses, for example for travel costs. The exact amount of this compensation can vary from study to study.

We mainly search for phase II and phase III clinical trials in haematology and oncology. In these phases, the treatment has already shown that it is basically safe and tolerable.
Phase III studies are usually the final step before a drug is approved. However, it may still take several months or even years after a study is completed before a treatment becomes available to all patients.

OnkoPlus.co.uk is a service by iduneo GmbH